Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China flag China · Delayed Price · Currency is CNY
4.670
-0.050 (-1.06%)
Nov 17, 2026, 3:04 PM CST

SHE:002252 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,0851,5772,1931,7791,8801,295
Depreciation & Amortization
225.85225.85207.39163184.98159.27
Other Amortization
15.6515.6510.059.59.949.55
Loss (Gain) From Sale of Assets
-21.16-21.161.610.01-0.231.35
Asset Writedown & Restructuring Costs
92.7992.7913.234.31199.5370.45
Loss (Gain) From Sale of Investments
-352.86-352.86-513.51196.89-430.7742.76
Stock-Based Compensation
19.819.853.7821.61--
Provision & Write-off of Bad Debts
20.4120.4143.64-5.2216.38-10.83
Other Operating Activities
18.933.83-88.14-89.3-94.55-435.77
Change in Accounts Receivable
-387.33-387.33-1,229163.23-286.97-75.16
Change in Inventory
-757.89-757.89-638.98-417.74-106.32-1,014
Change in Accounts Payable
-765.81-765.81-542.72449.23333.94961.09
Operating Cash Flow
-835.44-328.69-482.062,2781,7261,294
Operating Cash Flow Growth
---32.01%33.35%10.71%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-481.34-384.82-407.15-450.8-225.73-204.61
Sale of Property, Plant & Equipment
61.23.190.332.332.243.19
Cash Acquisitions
-196.94-3,704-34-440.69--
Investment in Securities
878.551,828-775.21141.72-946.68-609.51
Other Investing Activities
-28.855.42300.1176.8439.9780.11
Investing Cash Flow
232.62-2,252-915.92-670.59-1,130-730.82

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-3,660----
Total Debt Issued
2,1443,660----
Short-Term Debt Repaid
------7.74
Long-Term Debt Repaid
--301.56-4.65-2.04-5.73-4.21
Lease Payments
-5.57-5.57-2.01-2.04-5.73-4.21
Total Debt Repaid
-841.14-301.56-4.65-2.04-5.73-11.95
Net Debt Issued (Repaid)
1,3033,358-4.65-2.04-5.73-11.95
Issuance of Common Stock
--15.57113.17--
Repurchase of Common Stock
-478.01-478.01-2.27-1,000--
Common Dividends Paid
-418.4-258.58-439.85-202.22-188.74-168.52
Other Financing Activities
315.42-54.5-33.2-43.131.091.19
Financing Cash Flow
722.272,567-464.41-1,134-193.38-179.28

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
20.5416.791.32-3.3111.75-2.26
Net Cash Flow
140.013.26-1,861469.77413.78381.66

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,317-713.52-889.21,8271,5001,089
Free Cash Flow Growth
---21.82%37.68%18.79%
Free Cash Flow Margin
-21.23%-9.71%-10.88%22.94%22.84%25.41%
Free Cash Flow Per Share
-0.20-0.11-0.130.280.220.16
Levered Free Cash Flow
-1,840-1,055-1,2231,5931,180748.69
Unlevered Free Cash Flow
-1,789-1,027-1,2231,5941,180748.99
Free Cash Flow After Leases
-1,322-719.08-891.221,8251,4941,085

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.03
Cash Income Tax Paid
637.25621.13825.58644.74593.92339.12
Change in Working Capital
-1,940-1,940-2,403197.6-39.73-137.29